BioCentury
ARTICLE | Top Story

FDA gets feedback on next-generation sequencing

February 28, 2015 2:37 AM UTC

As FDA digests comments from last week's next-generation sequencing (NGS) (see BioCentury Extra, Feb. 18).

Mansfield noted that a challenge FDA will face as it moves forward with NGS regulation is ensuring that the tools and standards developed can be easily implemented by laboratories. She added that panelists were concerned with how FDA would then assess compliance with established standards. Public comments on the NGS workshop are open until March 20. ...